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Investigations  of  the  anomalous  proteins  associated  with  multiple  myeloma and 
related  diseases have facilitated  recognition of separate  classes  of immunoglobulins. 
Waldenstr6m's  studies  in  macroglobulinemia  (1)  emphasized  the  existence  of  IgM 
(3'1~a-, /3~M-macroglobulins).  A  distinctive  class of myeloma protein  of beta globulin 
electrophoretic mobility and  characteristic antigenic properties was recognized  (2-6) 
prior to the identification of the corresponding IgA (3'1A-,/32A-globulins) by immuno- 
electrophoresis of normal serum  (7). Bence Jones proteins, pathological counterparts 
of -y-microglobulins, were recognized for over 100 years before the corresponding nor- 
mal proteins were identified  (8). 
In  the  course  of  studies  of  human  myeloma  proteins,  a  unique  myeloma 
protein  was identified  in  the  serum Of a  patient  S.  J.  (9).  This  S.  J.  myeloma 
protein  was  distinguished  from  typical  G  (3'~) myeloma  proteins,  A  ('Y1A) 
myeloma proteins,  M  macroglobulins  of WaldenstrSm,  and  Bence  Jones  pro- 
teins  in  several  parameters  (9).  In  the  light  of  the  historical  evidence  that 
anomalous proteins are closely related to normal serum components, a  thorough 
study of normal proteins was undertaken  in an effort to find a  normal counter- 
part  to  the  unique  S.  J.  myeloma protein.  This effort was successful  and  this 
paper describes a  previously unrecognized  class of immunoglobulins. 
Proteins  of this  new  class  are  here  referred  to as IgD,  on  account  of many 
features  which  indicate  that  they are members of the  immunoglobulin  family, 
as well as other properties  indicating  that  they constitute  a  separate  and  pre- 
viously unrecognized  class of immunoglobulin. 
Materials and Methods 
Ouchterlony  analysis  and  immunoelectrophoresis  were  performed by standard  methods 
(10). Antiserums  to IgD were prepared by immunizing  rabbits with  S. J. myeloma protein 
as described  in the accompanying paper (9). The antiserums were made specific for IgD by 
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absorption in three different ways: First by absorption with a  G  myeloma protein of type L, 
followed by absorption with agammaglobulinemia serum; secondly, by absorption with IgG 
from normal serum followed by absorption with agammaglobulinemia serum; and thirdly by 
absorption with a  small volume of normal human serum. Similar results were obtained using 
all three absorbed antiserums. The antiserum used for most of these studies was prepared by 
absorption of 5 ml of antiserum to S. J. myeloma protein with 0.5 ml of a normal human serum 
of low IgD level. Antiserums to IgG, IgA, and IgM, and to type K  and type L  Bence Jones 
proteins have been described  (10). 
Gel filtration on sephadex G-200 was performed using a  4  x 46 cm column equilibrated in 
0.2 ~  NaC1, 0.2 M pH 8.0 tris HC1. Material to be fractionated was applied to the column in 
20 per cent sucrose to ensure an initial narrow band. The proteins were eluted witb the same 
buffer, and collected as 6  or  10 ml fractions. 
For chromatography on diethylaminoethyl (DEAE)  cellulose, 5 ml of serum was dialyzed 
against 0.015 M pH 8.0 potassium phosphate buffer, and applied to a  2 x 22 cm column con- 
taining 8  gm of DEAE  cellulose equilibrated  with the same buffer.  Elution was performed 
using 500 ml of buffer in a  gradient from 0.015 to 0.3 ~  at pH 8.0 (10).  For the isolation of 
IgD 12 ml of serum from patient C. C. was fractionated in the same manner. 
Quantitative Determination of IgD.--Levels  of IgD  and  other  immunoglobulins were  de- 
termined by diffusion tests in agar plates with specific antiserum incorporated into the agar 
(11,  12). The procedure employed has been described in detail  (12).  Specifically for IgD de- 
termination serum or serum fractions were added  to small holes in the antibody-agar plate 
and allowed to diffuse for 16 hours at 6°C. The diameter of the circular precipitin rings which 
developed around the holes was measured. Values for protein concentration were obtained by 
comparison of these ring diameters with the diameters of rings produced by a  series of con- 
centrations of the protein  in  a  standard reference serum in other holes on the  same plate. 
The specific antiserum for IgD estimations was diluted 40-fold in the antibody-agar plate. A 
buffer of 0.3 M pH 8.0 potassium phosphate was used in preparing the plates to avoid the for- 
mation of non-specific precipitates around the holes which sometimes appeared when buffers 
of lower salt content were used. 
A normal serum of relatively high IgD content was selected for use as a  standard. A series 
of dilutions of this serum was prepared which yielded precipitin rings in the agar plate ranging 
from 6.0 mm for undiluted serum to 3.3 mm for the serum diluted to  1:40.  Dilutions of this 
serum between 1:50 and  1:100 gave detectable precipitates which were not, however, meas- 
urable as rings. Reactions of this intensity were recorded as 1 per cent of the concentration of 
the standard serum. The  IgD content of the standard serum was determined by comparison 
with purified preparations of the S. J.  myeloma protein and the isolated IgD from serum of 
patient  C. C., prepared  as described below.  Estimates of the concentration of these proteins 
were based on optical density measurements at 280 In#, assuming an extinction coefficient of 
13.5. The IgD concentration in the standard serum was found to be 0.34 mg/ml when com- 
pared with S. J. myeloma protein, and 0.32 mg/ml when compared with isolated IgD. Although 
some error might be anticipated in the comparison with the S.  J. myeloma protein because of 
myeloma specific determinants reactive with  the  antiserum, this error  was  not large,  since 
the values obtained with the two protein preparations were similar. The mean value of 0.33 
mg/ml was assigned to the standard serum. Errors may arise in this quantitative method if 
the proteins being measured differ in molecular size (12). This problem does not arise, however, 
in the case of IgD since these proteins appear  to be homogeneous in size as indicated  by a 
single peak on sephadex G-200 filtration  of three normal serums (see Results). 
RESULTS 
Identification  of a Normal Serum Globulin (IgD) Anligenically Related to the 
S.  J.  Myeloma  Protein.--Immunochemical  techniques  were  used  to  demon- 187 
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strate  a  protein  in  normal serum  which  is  antigenically related  to  the  S.  J. 
myeloma protein. The immunochemical technics required antiserum reacting 
only with  the  new  class  of  immunoglobulin.  Such  specific antiserums  were 
prepared by immunizing rabbits with the purified S.  J. myeloma protein and 
by absorbing the antiserum so that they did not react with IgG, IgA, or IgM 
or the non-immune globulins of serum (see Materials and Methods). 
Immunoelectrophoretic analysis  of  appropriate  normal  serums,  developed 
with specific antiserum to S. J. myeloma protein, revealed a  single precipitin 
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FIG. 3.  Distribution of IgD concentrations in serums from 72 normal adult males and 28 
normal adult females. 
arc in  the normal serum  (Fig.  1).  Ouchterlony analysis in Fig.  2 shows that 
normal serum A gave a  single precipitin line with the specific antiserum. The 
precipitin line formed in normal serum joined the precipitin line given by the 
isolated  S.  J.  myeloma protein  and  indicated  that  the  two  proteins  shared 
specific antigenic determinants; i.e.,  the normal serum globulin was antigeni- 
cally related to the S. J. myeloma protein. 
Concentration  of IgD in Normal Human Serums.--IgD  concentrations were 
measured by a  quantitative gel diffusion method, using antiserum specific to 
the protein. Serums were obtained from 72 normal males, aged 19 to 57 years, 
and 28 normal females, aged 20 to 54 years. The serum IgD concentrations of 
this group varied widely (Fig. 3), ranging from less  than the limit of detect- 
ability, i.e.,  <0.003  mg/ml,  to as  high  as 0.4 mg/ml.  The  values  were  not 
distributed  in  a  Gaussian  manner  within  this  range  (Fig.  3).  Sixty-nine per 190  HUMAN  IMMUNOGLOBULINS.  II 
cent  of  the  serums  had  values  between  0.02  and  0.05  mg/ml.  The  median 
serum IgD  concentration was 0.03  mg/ml. 
IgD  concentrations  showed  similar distributions in  both  male  and  female 
populations (Fig. 3). There was no correlation between age and concentration 
(rank correlation =  0.09, p  >  0.1). A group of 17 healthy children between  the 
ages of 2  and  11  years were also studied and found  to have values similar to 
o  ~  1.5 
mk 
E::  E  I0 
~--P~  O5 
o 
Q_ 
~  o.~ 
E 
0,0 
~zk  10 
00 
<X  E  ~  02 
E 
O0 
,=,~,  10 
E 
oo 
/,  h  i 
200  400 
I 
r~ 
i 
//  i  ___ 
200  400  200  400 
ELUTED  VOLUME(ml) 
FIG. 4.  Distribution of immunoglobulins of three normal serums following gel filtration on 
sephadex G-200. Serum 1 contained  IgG 12.5 mg/ml, IgA 0,14 mg/ml, IgM 1.5 mg/ml, and 
IgD 0.33 mg/ml. Serum 2 contained  IgG 6.1 mg/ml, IgA 0.65 mg/ml, IgM 1.05 mg/ml, and 
IgD 0.15 mg/ml. Serum 3 contained  IgG 10.6 mg/ml, IgA 6.8 mg/ml, IgM 1.4 mg/ml, and 
IgD 0.16 mg/ml. After determination of optical density the fractions eluted from the column 
were uniformly concentrated 8 times by ultrafiltration. Immunoglobulin  concentrations were 
estimated by the antibody-agar plate technic.  Results are shown as the concentration calcu- 
lated to be in each fraction prior to ultrafiltration. 
the adult levels. Levels ranged between 0.007 and 0.17 mg/ml, the median was 
0.03  mg/ml.  There was no significant correlation of serum level with the age 
of these  children  (rank correlation  =  0.34,  p  >  0.1).  IgD  was  not detected, 
however, in the serums of two healthy infants aged 4 months. 
Physicochemical Characteristics.--Immunoelectrophoresis  (Fig.  1)  revealed 
normal IgD  in  the  fast 3,-region. The  form  of  the IgD  precipitin line differs 
from  that  of  the  other  three  immunoglobulins  (Fig.  1).  IgD  are electropho- 
retically heterogeneous. 
Gel filtration on sephadex G-200 columns was used to characterize IgD and DAVID  S.  ROWE  AND  JOHN  L.  FAHEY  191 
the other normal serum immunoglobulins  (Fig. 4). Three normal serums were 
fractionated with similar results. The serum proteins were eluted in three major 
peaks corresponding  to  the  18S,  7S,  and  4.5S  components of normal  serum. 
IgD  was  eluted  from  the  column  as  a  fairly  symmetrical peak  in  fractions 
midway between the first and second optical density peaks (Fig. 4); i.e.,  in a 
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FzG. 5.  Distribution of immunoglobu]ins of two normal serums following chromatography 
on DEAE cellulose columns (serums 2 and 3 of Fig. 4). After determination of optical density, 
Ouchterlony analysis was used to localize IgD in the fractions. Fractions from the region in 
which the protein was detected were uniformly concentrated  10-fold  by ultrafiltration,  and 
their  concentration  of  immunoglobulins then  determined.  Results are  shown  as  the  con- 
centration calculated  to be in the fraction prior  to ultrafiltration.  IgM was not detected in 
the concentrated fractions representing 35 to 70 per cent of the effluent but was localized in 
fractions eluted later from the column. 
region between (and separate from) IgM and IgG. lgD was also  distinct  from 
IgA in their manner of elution from the columns.  IgI) was  eluted  as  a  single 
peak,  with no evidence of heterogeneity of molecular size,  whereas  IgA  was 
eluted over a  broader range of fractions and showed two concentration peaks 
(Fig. 4, serums 2 and 3). 
Chromatography  on  diethylaminoethyl  (DEAE)  cellulose  columns  was 
also  used  to  characterize  IgD.  Two  normal  serums  were  fractionated  with 
similar  results  (Fig.  5).  IgD  were  eluted  as  a  symmetrical peak  in a  region 192  HUMAN  IMMUNOGLOBULINS.  II 
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intermediate between the second optical density peak, which contains trans- 
ferrin, and the third optical density peak, which includes the bulk of the serum 
albumin. IgD  was  clearly different in chromatographic properties from other 
classes  of immunoglobulin. Most of the IgG was eluted in the first chromato- 
graphic  peak.  IgM  is  eluted after  IgD.  The  IgD  and  IgA  are  eluted  close 
together and with some overlapping. IgD, however, appeared in earlier eluate 
fractions and formed a narrower peak than did IgA (Fig. 5); differences which 
are consistent with the narrower range and slower mobility of IgD compared 
with IgA on immunoelectrophoretic analysis (Fig. 1). 
Preparation of IgD.--IgD was prepared from normal serum by the technics 
noted above but in each case the preparations contained IgA and IgG. Although 
the  absolute  amounts  of  these  contaminants  were  low,  they constituted  a 
significant proportion of the preparations because only small amounts of IgD 
were  present  in  the normal  serum  from which preparations  were made.  To 
avoid the difficulties of separation from IgG and IgA, IgD has been isolated 
from the serum of a  15-year-old patient C. C., who was deficient in IgG and 
IgA. The IgD and the IgM concentrations in this serum were relatively high. 
Details of this patient's illness are reported elsewhere (13). 
Twelve ml of serum were fractionated by DEAE cellulose chromatography 
(Fig. 6). The first (IgG) peak was very much reduced. IgD was eluted in flac- 
tions in the same region as Fig. 4, and IgG and IgA could not be detected in 
these fractions. The IgD fractions were pooled and concentrated to 3 ml, and 
then applied  to a  sephadex G-200  column. Three protein peaks appeared  in 
the eluate of this column (Fig. 6), and IgD  was  confined to the second peak. 
Fractions from this peak were pooled, and concentrated by ultrafiltration to 
an optical density of 1.60 at 280 m#. 
Ouchterlony analyses (Fig. 7)  indicated that the isolated protein contained 
specific  IgD antigenic determinants and was not contaminated by IgG, IgA, 
and  IgM.  A  horse anti-human  serum  indicated an  absence  of non-immuno- 
globulin contaminants. 
Distinctive Antigenic Properties.--The antigenic distinctiveness of IgD  was 
shown  by  several  tests.  Antiserum  reacting  specifically with  IgD  failed  to 
react with normal IgG, IgA, or IgM (Fig. 7). Similarly, antiserums specific for 
each of these proteins failed to react with isolated IgD  (Fig. 7). 
The antigenic relationship of normal IgD  and  the  S.  J.  myeloma protein 
was  typical  of  a  myeloma protein  and  the  corresponding  normal  immuno- 
globulin. Ouchterlony analysis (Fig. 2) showed that the S. J. myeloma protein 
formed a  precipitin line which extended as a  spur beyond the precipitin line 
formed by IgD of normal serum. This spur formation is typical of Ouchterlony 
test results when a myeloma protein is compared with normal immunoglobulin 
using antiserum prepared against the myeloma protein (14). The spur indicates 
that  the myeloma protein has  one or more  antigenic determinants  that  are 194  HUMAN  IMMUNOGLOBULINS.  II 
either not present in normal immunoglobulins or are present in very low con- 
centration (14). 
Antigenic Determinants of L Polypeptide Chains in IgD.--Isolated IgD  from 
C.C.  serum was tested with  two antiserums specific to type K  (I)  light  chain 
Fro. 7.  Ouchterlony  analysis showing antigenic distinctiveness of isolated IgD. IgG, IgA, 
and IgM were obtained from normal serum,  IgD from  C.C.  serum.  Protein concentrations 
were 0.2 mg/ml. The antiserum (AS) is designated  below each  test.  Antiserums specific for 
IgG, IgA, and IgM fail to react with isolated IgD, but do react with proteins of appropriate 
class isolated from normal serum.  Specific antiserum to IgD reacts with the isolated protein, 
but not with the other immunoglobulins. 
determinants  and  two  antiserums specific to  type L  (II)  light chain  determi- 
nants.  Under appropriate conditions, all four antiserums  reacted with  IgD  or 
its constituent polypeptide chains (Table I). This indicates that IgD possesses 
type K  (I) and type 1, (II) light polypeptide chains. In this characteristic, IgD 
is similar to normal IgG, IgA, and IgM. DAVID  S.  ROWE  AND  JOHN  L.  FAHEY  195 
A  series of observations, summarized in Table I, indicated  that some of the 
type K  (I) and type L  (II) antigenic determinants  in the intact molecule were 
not able to yield precipitin lines with specific antiserum.  One of the antiserums 
to type K  (I) determinants precipitated  isolated IgD; the second did not. This 
latter  antiserum  also failed  to react with reduced and alkylated  IgD, but did 
precipitate  with  light  polypeptide  chains  after dissociation  of the  constituent 
polypeptide  chains by acidification with  1 M acetic  acid.  Similar  results  were 
TABLE I 
Ouchterlony Analyses of Isolated IgD and S. J. Mydoma Protein and Their Separated 
Polypeptide Chains 
Isolated protein ........... 
Reduced and alkylated ..... 
Reduced,  alkylated,  and 
acidified ................ 
Reduced,  alkylated,  acidi- 
fied, and neutralized ..... 
Anti-type 
K  (I) 
Anti-  Anti 
BJ  IgC  (ab: 
0  + 
0  + 
+  + 
+  + 
IgD 
Anti-type 
L  (II) 
Ant!  Anti-  IgC 
)  BJ  __(ab~ 
+  ; 
+ 
+  + 
+  + 
S. J. myeloma protein 
Anti-type 
K  (I) 
Anti-  Anti- 
IgG 
BJ  (abs) 
0 
0 
0 
0 
Anti-type L  (II) 
Anti-  Anti-IgG 
BJ  (abs) 
0  0or +* 
+  0or +* 
+  + 
+  + 
Proteins were tested after reduction and alkylation, and reduction, alkylation, and acidifi- 
cation  in  1 M acetic  acid according to the method  of Fleischman, Pain, and Porter.  These 
preparations  were neutralized  by dialysis for 16 hours at 4°C against 0.14 M NaC1, 0.1 ~t pH 
8.0 potassium phosphate  buffer. 
+  indicates  a precipitin  line, 0 indicates  no reaction.  Agar plates  prepared  with  0.3 M 
pH 8.0 potassium phosphate buffer. Anti-type K (I) antiserums were prepared by immunizing 
rabbits with type K (I) Bence Jones protein  (anti-B J) or by absorbing antinormal  IgG by a 
Type L (II) G myeloma protein  (Anti-IgG abs). Anti-type L (II) antiserums were similarly 
prepared. 
* Some antiserums gave no reaction  (0) and others produced a positive reaction  (+) with 
S. J. myeloma protein. 
obtained  on  studying  the  type L  (II)  light  chain  determinants  of  the  S.  J. 
myeloma protein. These were inactive with both antisera to type L  (II) deter- 
minants prior to reduction and alkylation,  and only became strongly reactive 
after  separation  of  light  and  heavy  polypeptide  chains. 
These findings show that  the  light polypeptide chains  of IgD possess anti- 
genic determinants  in common with  type K  (I) and  type L  (II) Bence Jones 
proteins.  Certain  of  these  are  apparently  unreactive  in  the  intact  molecule 
but  become  reactive  following  separation  of  light  from  heavy  polypeptide 
chains.  Similar  observations have been made  on other  immunoglobulins  (15- 196  HUMAN  IMMUNOGLOBULINS.  II 
18)  and indicate that-such  "hidden" light chain determinants are not unique 
to IgD. 
DISCUSSION 
A distinct class of human globulins has been identified and designated IgD. 
Many features indicate that IgD proteins are members of the immunoglobulin 
family. Isolated normal IgD contains antigenic determinants of type K  (I) and 
type L  (II) light polypeptide chains.  Since such chains are constituents of all 
classes of immunoglobulins, their presence in IgD proteins is strong evidence 
for regarding these proteins as immunoglobulins. The electrophoretic mobility 
and the size characteristics of IgD also are similar to other classes of immuno- 
globulins.  IgD  was  not  detected  in  agammaglobulinemic serums, nor in  the 
serum  of  young  infants.  In  cases  of  multiple  myeloma  and  of  macroglob- 
ulinemia  with  reduced  concentrations  of  other  normal  immunoglobulins, 
IgD  was usually  undetectable. A  myeloma protein,  related  to  normal  IgD 
has been identified (9). Elevated serum levels of IgD have been found in some 
patients  with  chronic  infectious  diseases.  These  observations,  together  with 
evidence from the structural analyses of the protein, indicate a close relation- 
ship between IgD and other proteins of the immunoglobulin system. 
One  of  the  major  distinctive  features of IgD  is  antigenic  specificity. The 
antigenic  specificity  of  IgD  is  associated  with  distinctive  physicochemical 
properties. Although IgD  shares some  properties with other immunoglobulins 
which  migrate  in  the  3q-electrophoretic  region,  studies  with  sephadex  gel 
filtration and DEAE cellulose chromatography show that each immunoglobulin 
class is eluted in a different manner. Heterogeneity of IgG and IgA, however, 
prevents  isolation of IgD  by the  usual methods of serum  fractionation. 
IgD  does not  possess  the  specific antigenic determinants  characteristic  of 
IgG, IgA, or IgM and thus does not appear to be a subclass of one of the three 
known  immunoglobulin  groups.  In  addition,  IgD  can  be distinguished  from 
the 3'~-, 3'2u-, and 3,2o-subclasses of IgG which are recognized by monkey anti- 
serums  (19-24). Antiserums specific for these three subclasses of IgG (25)  do 
not  react  with  IgD  preparations.  Also,  antiserum  specific for  IgD  does  not 
react with representative 3'2~-, 3'eb-, or 3,2c-myeloma proteins or with a  fourth 
subclass tentatively designated "Y2d (26)  or with representative proteins of the 
four IgG subclasses described by Grey and Kunkel (22). This immunochemical 
evidence indicates that  IgD  is  a  separate class of human immunoglobulin. 
The terminology IgD is proposed for the new class of serum protein described 
here: Ig, on the basis of evidence that these proteins are members of the im- 
munoglobulin family, D  because of the evidence that the distinctive properties 
lie  in  the  heavy  polypeptide  chains  and  the  properties  are  sufficiently 
unique to clearly differentiate these proteins from IgG, IgA, and IgM classes, 
or from known subclasses of these groups. DAVID  S.  ROWE  AND  JOHN  L.  FAHEY  197 
Normal serum immunoglobulins can be classified on the basis of the major 
categories of heavy and  light  polypeptide chains.  Six commonly recognized 
immunoglobulins are formed by combination of ~ (type I) or X (type II) light 
chains with % a, or # heavy chains (Fig. 8). The present studies, and related 
studies of the S. J. myeloma protein (9), indicated that a fourth type of heavy 
polypeptide chain, 6, may be associated with K or X (type I  or type II) light 
chains. With the addition of two types of IgD molecules, the number of nor- 
mal serum immunoglobulin forms is increased to eight. These are schematically 
shown in Fig. 8. 
Many  specific properties of individual  classes  of immunoglobulins  depend 
on the properties of their heavy polypeptide chains. Thus, the inference that 
the Ig  D  has distinctive heavy polypeptide chains, 6, raises the possibility that 
these proteins will have a specific and distinctive role in the immune response. 
IgG 
K  y  X  y 
IgA 
IgM 
IgD 
12  11 
/x  /x 
Type K(I)  Type L(]I) 
FIG. 8.  Schematic representation of the light and heavy polypeptide chains associated with 
eight forms of normal serum immunoglobulins. 
Studies are underway to determine the function of IgD  and  to compare the 
biological properties  of  these  proteins  with  those  of  other  members  of  the 
immunoglobulin family. 
The wide range of serum levels of IgD found in normal populations remains 
to be explained. Individual normal serums showed over 100-fold variation in 
content of this protein, a much wider range from that observed for other classes 
of immunoglobulin (12). Preliminary studies indicate, however, that the serum 
level in one individual may remain constant over a  period of years.  Genetic 
factors, as well as environmental factors, may help to fix the serum level of 
IgD but additional studies will be needed to assess properly these possibilities. 
SUMMARY 
A new class of immunoglobulin, IgD, was identified in normal human serum 
by  immunochemical  technics.  Antiserums  prepared  against  the  unique  S.J. 
myeloma protein facilitated recognition of the related normal protein. IgD  was 
shown to possess type K  (I) and type L  (II) light chain determinants, similar 198  HUMAN  IMMUNOGLOBULINS. lI 
to  those  present  in  other  classes  of  immunoglobulins.  IgD  does  not  possess 
determinants which are specific to IgG, IgA, or IgM. The IgD proteins possess 
their own specific antigenic  determinants.  IgD migrates in the fast 3,-region on 
immunoelectrophoresis.  The  properties  on  sephadex  gel filtration  and DEAE 
cellulose chromatography are described. 
IgD was  found  to have a median level of 0.03 mg/ml in 100 normal serums. 
The range of concentrations  found in individual normal serums is much wider, 
however,  than  that of other classes of immunoglobulins.  IgD, on the average, 
accounts  for less  than  1  per  cent  of  the  normal  serum  immunoglobulins. 
The authors wish to thank Mrs. E. W. Wirtz for ultracentrifugal  analyses. 
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